At Acino, we make high-quality medicines accessible to patients and healthcare professionals where and when it’s needed most. We develop, manufacture and internationally market innovative and well proven pharmaceuticals in selected high-growth markets.
Over the years, we have successfully expanded our portfolio through in-licensing and acquisitions and are well positioned for growth. We work closely with our partners to bring effective and innovative drugs to the markets where we operate. Our world-class manufacturing capabilities and network are also leveraged by other pharma companies, making us their contract manufacturing and out-licensing partner of choice.
Acino is a Swiss pharmaceutical company with a clear focus on the Middle East, Turkey, Africa, Ukraine, the CIS region, and Latin America markets. Our diverse portfolio is made of prescription (Rx) medicines and over-the-counter (OTC) products, as well as a wide range of food supplements. We provide originator brands which are protected by patents or data exclusivities, and branded generic drugs which are equivalent substitutes to their originator products.
Not all treatments are available in all countries and marketing authorisations vary from country to country. Visit our local websites and contact us for more information.